Aurora Cannabis (NYSE:ACB) and Actelion (OTCMKTS:ALIOF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.
This table compares Aurora Cannabis and Actelion’s net margins, return on equity and return on assets.
Earnings and Valuation
This table compares Aurora Cannabis and Actelion’s top-line revenue, earnings per share and valuation.
Actelion has higher revenue and earnings than Aurora Cannabis.
Institutional Insider Ownership
8.2% of Aurora Cannabis shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Aurora Cannabis has a beta of 2.9, meaning that its stock price is 190% more volatile than the SP 500. Comparatively, Actelion has a beta of 0.93, meaning that its stock